Kommentar
Local Ablative Therapy in Oligometastatic Breast Cancer—Equipoise Persists
JAMA Surgery · 01.05.2026 · 161 (5) · 477
DOI: 10.1001/jamasurg.2026.0106 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Surgery, erschienen am 01.05.2026. Verfasst von Leah Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Yale New Haven Hospital, New Haven, Connecticut. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Surgery, Yale New Haven Hospital, New Haven, Connecticut.
Zitieren
APA
Kim, L., Morton, C. R., & Golshan, M. (2026). Local Ablative Therapy in Oligometastatic Breast Cancer—Equipoise Persists. JAMA Surgery, 161(5), 477. https://doi.org/10.1001/jamasurg.2026.0106
Vancouver
Kim L, Morton CR, Golshan M. Local Ablative Therapy in Oligometastatic Breast Cancer—Equipoise Persists. JAMA Surgery. 2026;161(5):477. doi:10.1001/jamasurg.2026.0106
BibTeX
@article{Kim2026,
author = {Kim, Leah and Morton, Claire R and Golshan, Mehra},
title = {Local Ablative Therapy in Oligometastatic Breast Cancer—Equipoise Persists},
journal = {JAMA Surgery},
year = {2026},
volume = {161},
number = {5},
pages = {477},
doi = {10.1001/jamasurg.2026.0106}
}
EUVIMED